Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha variable 10 (TRAV10) encodes the variable region of the alpha chain of the T cell receptor (TCR), which is essential for the recognition of peptide-major histocompatibility complex (pMHC) complexes presented by antigen-presenting cells[1][3]. The TRAV10 gene is part of the TCR alpha locus and contributes to the diversity of antigen recognition through genetic recombination during T cell development[1][2][3]. The product of TRAV10 is involved in the formation of the αβ T cell receptor, necessary for adaptive immunity, T cell signaling, and proper immune surveillance. T cell receptors, including those containing TRAV10, play a key role in mounting immune responses to infections, cancer, and other immunopathologies, and aberrant T cell signaling can be implicated in autoimmunity and other immune-related diseases[1][2]. Currently, there are no known direct drug interactions specifically targeting TRAV10, nor is it established as a standalone clinical biomarker or as having unique safety concerns; the clinical focus is generally at the level of the full TCR complex or T cell function as a whole[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha variable 10 (TRAV10).